Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIOcomb Study
2007-006706-14Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone and metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Takeda. Primary endpoint: Change in MMP9 from baseline to 6 months. Started Jan 2008; status: completed.
02
Drugs
pioglitazonemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-006706-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006706-14.